(secondQuint)Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients.

 All cases of hepatitis C whether cirrhotic, post organ transplant, co-infected with HIV or hepatitis B, active drug abuse, on immune suppression and from all genotypes will be included.

 Patients will be treated by a single daily dose of a fixed-dose combination pill of 400mg sofosbuvir and 60 mg daclatasvir for 12 weeks.

 If a patient is cirrhotic, defined by liver stiffness > 12 kilopascal, either weight based ribavirin will be added or the treatment duration will be prolonged to 24 weeks.

.

 Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients@highlight

The fixed-dose combination of sofosbuvir and daclatasvir in a single pill is being used for the treatment of hepatitis C in Iran.

 In this study the efficacy of this combination is evaluated in 1000 patient with hepatitis C.

